Kisspeptin Physiology in Human Reproduction
Kisspeptin 人类生殖生理学
基本信息
- 批准号:8537499
- 负责人:
- 金额:$ 17.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-10 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultClinicalClinical InvestigatorComplexContinuous InfusionDevelopmentDiagnosticEducational process of instructingEndocrineFemaleFinancial SupportGenesGeneticGenotypeGoalsGrantHumanInfertilityKISS1R geneKlinefelter&aposs SyndromeKnowledgeLuteal PhaseMalignant NeoplasmsManuscriptsMentorsMutationNeoplasm MetastasisNeurokinin BNeuronsNeuropeptidesPathway interactionsPatientsPhenotypePhysiologyPopulationPropertyProtocols documentationReproductionReproductive BiologyReproductive PhysiologyResearchResearch PersonnelResourcesRewardsSignal PathwaySignal TransductionTACR3 geneTherapeutic InterventionTimeTrainingTraining ProgramsTranslatingWomanWorkWritingcareerdesensitizationdesignendometriosisexperiencehealth knowledgehealthy volunteerhigh standardkisspeptinmeetingsmennext generationnovelpatient oriented researchpatient safetyprogramsproliferative phase Menstrual cyclepubertal timingreceptorreproductiveresponseskills
项目摘要
DESCRIPTION (provided by applicant): The purpose of this grant is to seek financial support for mentoring activities in patient -oriented research to allow young trainees to experience the excitement of scientific discovery. By mentoring, this applicant hopes to build the next generation of clinician investigators by having them experience the wonderful rewards of taking new biologic and health knowledge they have discovered and translating that knowledge into tangible benefits for patients, such as better diagnostic strategies or novel clinical therapies. In order to support such training efforts, this grant would provide financial resources for the applicant, so that she could maintain her own research program while freeing up time for mentoring activities. These mentoring activities involve teaching trainees how to build hypotheses, design protocols, achieve the highest standards of patient safety, address regulatory issues, develop manuscripts, write grants, and meet their career goals. The trainees will work within the applicant's research program in reproductive genetics and physiology. The applicant discovered that mutations in the kisspeptin-GPR54 signaling pathway result in an absence of pubertal development and hypogonadotropic hypogonadism across mammalian species. She is now using kisspeptin administration as the first direct probe of GnRH neuronal integrity in human reproductive biology. Study protocols will include healthy volunteers and patients with congenital GnRH deficiencies who have already been extensively phenotyped and genotyped. Kisspeptin (or analogous compounds) may provide another avenue for therapeutic intervention for patients with reproductive cancers, endometriosis, infertility, and abnormalities of pubertal timing. Patients with reproductive cancers may derive additional benefits given the metastasis suppressor properties of this pathway. Taken together, these projects and the applicant's mentoring will provide a strong program for training new clinical investigators in patient-oriented research.
描述(由申请人提供):此笔赠款的目的是为面向患者的研究中的辅导活动寻求财政支持,让年轻学员体验科学发现的兴奋。通过指导,该申请人希望通过让他们体验他们发现的新生物学和健康知识并将这些知识转化为患者的切实利益(例如更好的诊断策略或新型临床疗法)的美妙回报,来培养下一代临床研究人员。为了支持这种培训工作,这笔赠款将为申请人提供财政资源,使她能够维持自己的研究计划,同时腾出时间进行指导活动。这些指导活动包括教学员如何建立假设,设计方案,实现患者安全的最高标准,解决监管问题,开发手稿,撰写赠款,并实现他们的职业目标。受训人员将在申请人的生殖遗传学和生理学研究计划中工作。申请人发现,kisspeptin-GPR 54信号通路中的突变导致哺乳动物物种中青春期发育和低促性腺激素性性腺功能减退症的缺失。她现在使用kisspeptin管理作为人类生殖生物学中GnRH神经元完整性的第一个直接探针。研究方案将包括健康志愿者和先天性GnRH缺乏症患者,这些患者已经进行了广泛的表型和基因分型。Kisspeptin(或类似化合物)可能为生殖系统癌症、子宫内膜异位症、不孕症和青春期时间异常的患者提供另一种治疗干预途径。考虑到该途径的转移抑制特性,生殖系统癌症患者可能会获得额外的益处。综合考虑,这些项目和申请人的指导将为培训新的临床研究人员提供一个强有力的计划,以患者为导向的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephanie Beth Seminara其他文献
Stephanie Beth Seminara的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephanie Beth Seminara', 18)}}的其他基金
Phase 2 Kp-10 in Patients with Hypogonadotropic Hypogonadism
低促性腺激素性性腺功能减退症患者的 2 期 Kp-10
- 批准号:
10730209 - 财政年份:2023
- 资助金额:
$ 17.52万 - 项目类别:
Project 1 - Deciphering the Molecular Drivers of Rare Forms of Human Infertility Using Integrative Genomic, Cellular, and Phenomic Approaches
项目 1 - 使用综合基因组、细胞和表型组方法破译罕见人类不孕症的分子驱动因素
- 批准号:
10463545 - 财政年份:2021
- 资助金额:
$ 17.52万 - 项目类别:
The Massachusetts General Hospital Harvard Center for Reproductive Medicine
马萨诸塞州总医院哈佛生殖医学中心
- 批准号:
10613357 - 财政年份:2021
- 资助金额:
$ 17.52万 - 项目类别:
The Massachusetts General Hospital Harvard Center for Reproductive Medicine
马萨诸塞州总医院哈佛生殖医学中心
- 批准号:
10463543 - 财政年份:2021
- 资助金额:
$ 17.52万 - 项目类别:
Project 1 - Deciphering the Molecular Drivers of Rare Forms of Human Infertility Using Integrative Genomic, Cellular, and Phenomic Approaches
项目 1 - 使用综合基因组、细胞和表型组方法破译罕见人类不孕症的分子驱动因素
- 批准号:
10613359 - 财政年份:2021
- 资助金额:
$ 17.52万 - 项目类别:
Phase 2 Kp-10 for Dopamine Agonist Intolerant Hyperprolactinemia IND 74,977
多巴胺激动剂不耐受高催乳素血症 2 期 Kp-10 IND 74,977
- 批准号:
10116170 - 财政年份:2018
- 资助金额:
$ 17.52万 - 项目类别:
Kisspeptin and Neurokinin B: Physiology in Monkey to Pathophysiology in Human
Kisspeptin 和 Neurokinin B:从猴子的生理学到人类的病理生理学
- 批准号:
9431349 - 财政年份:2017
- 资助金额:
$ 17.52万 - 项目类别:
Kisspeptin Physiology in Human Reproduction
Kisspeptin 人类生殖生理学
- 批准号:
8190179 - 财政年份:2011
- 资助金额:
$ 17.52万 - 项目类别:
相似海外基金
Novel forms of adult genetic white matter disorders: clinical-radiological phenotyping and identification of causal genes.
成人遗传性白质疾病的新形式:临床放射学表型和致病基因的鉴定。
- 批准号:
488945 - 财政年份:2023
- 资助金额:
$ 17.52万 - 项目类别:
Operating Grants
The Symmetry-HF Study: Symptom Dynamics and Clinical Biomarkers of Heart Failure in Older Adult Care Dyads After Heart Failure Hospitalization
Symmetry-HF 研究:心力衰竭住院后老年人护理二人组心力衰竭的症状动态和临床生物标志物
- 批准号:
10591584 - 财政年份:2022
- 资助金额:
$ 17.52万 - 项目类别:
Concordance Between Virtual and Clinical Measures of Child and Adult Height, Weight, and Neck Circumference: A Validity Sub-study (Jasmin Sanchez Diversity Supplement)
儿童和成人身高、体重和颈围的虚拟测量与临床测量之间的一致性:有效性子研究(Jasmin Sanchez 多样性补充)
- 批准号:
10711459 - 财政年份:2022
- 资助金额:
$ 17.52万 - 项目类别:
Agenda and priority setting for a swallowing clinical care pathway for adult critical illness survivors with tracheostomy
气管切开成人危重病幸存者吞咽临床护理途径的议程和优先事项设置
- 批准号:
461095 - 财政年份:2022
- 资助金额:
$ 17.52万 - 项目类别:
Miscellaneous Programs
Novel forms of adult leukodystrophies: clinical-radiological phenotyping and identification of causal genes
成人脑白质营养不良的新形式:临床放射学表型和致病基因的鉴定
- 批准号:
486255 - 财政年份:2022
- 资助金额:
$ 17.52万 - 项目类别:
Studentship Programs
The Symmetry-HF Study: Symptom Dynamics and Clinical Biomarkers of Heart Failure in Older Adult Care Dyads After Heart Failure Hospitalization
Symmetry-HF 研究:心力衰竭住院后老年人护理二人组心力衰竭的症状动态和临床生物标志物
- 批准号:
10449520 - 财政年份:2022
- 资助金额:
$ 17.52万 - 项目类别:
Clinical study for preoperative prediction of depression in older adult patients by deep learning and basic study for clarifying mechanism of depression and developing its prophylaxis.
通过深度学习术前预测老年患者抑郁症的临床研究以及阐明抑郁症机制和制定预防措施的基础研究。
- 批准号:
21H03022 - 财政年份:2021
- 资助金额:
$ 17.52万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Brain Plasticity and Clinical Consequences of Adult-Onset Asymmetric Hearing Loss
成人发病的不对称听力损失的大脑可塑性和临床后果
- 批准号:
10412442 - 财政年份:2021
- 资助金额:
$ 17.52万 - 项目类别:
Adult Changes in Thought (ACT) Research Program Core B: Clinical Core
成人思想转变 (ACT) 研究计划核心 B:临床核心
- 批准号:
10672348 - 财政年份:2021
- 资助金额:
$ 17.52万 - 项目类别:
Adult Changes in Thought (ACT) Research Program Core B: Clinical Core
成人思想转变 (ACT) 研究计划核心 B:临床核心
- 批准号:
10404972 - 财政年份:2021
- 资助金额:
$ 17.52万 - 项目类别: